ARCHIVES

FTC Report Disagrees With Key Provision Of Biologics Bill Backed By Companies

This article is from The Cancer Letter archive.

Vol. 35 No. 23 | June 12, 2009

Download PDF Visit The Full Archive

Related Articles

Cancer Accounts for 23% of U.S. Deaths, American Cancer Society Says.

January 21, 2005

Board Defers core Guideline changes, Asks Subcommittee For Alternate Plans

November 18, 1977

An Earmark For Pancreatic Cancer

August 3, 2012

Investigator Initiated Clinical Research Gets More For Less Money, Carbone Contends

April 13, 1979

FDA Committee IK IL-2/LAK For Modified Group C

May 1, 1987

Long-term Follow-up Shows ADH and ALH Tissue Abnormalities Can Carry Similar Risk

January 31, 2014